Resolving the Disproportionate Left Ventricular Enlargement in Mitral Valve Prolapse Due to Barlow Disease: Insights

K Carlos El-Tallawi1, Danai Kitkungvan2, Jiaqiong Xu3

  • 1Houston Methodist DeBakey Heart & Vascular Center, Houston, Texas, USA.

Insights

Prolapse volume contributes to total volume load in Barlow disease, explaining disproportionate left ventricular enlargement. Accounting for this volume load improves understanding of heart chamber remodeling.

Area of Science:

  • Cardiology
  • Cardiac Imaging
  • Valvular Heart Disease

Background:

  • Barlow disease features elongated mitral leaflets, leading to significant end-systolic prolapse volume.
  • Left ventricular (LV) enlargement in Barlow disease can appear disproportionate to mitral regurgitation (MR) severity, raising concerns about Barlow cardiomyopathy.

Purpose of the Study:

  • To investigate if total volume load, including transvalvular MR and prolapse volume, explains LV enlargement in Barlow disease.
  • To compare MR, prolapse volume, and cardiac remodeling between bileaflet prolapse (BLP) and single leaflet prolapse (SLP) using cardiac magnetic resonance (CMR).

Main Methods:

  • Cardiac magnetic resonance (CMR) was employed to assess patients with Barlow disease.
  • Evaluated mitral regurgitation (MR), prolapse volume, and cardiac chamber remodeling in 157 patients (81 BLP, 76 SLP).

Main Results:

  • Bileaflet prolapse (BLP) patients exhibited larger LV end-diastolic volume and prolapse volume despite similar transvalvular MR compared to single leaflet prolapse (SLP).
  • Total volume load, incorporating prolapse volume, correlated better with LV end-diastolic volume in BLP patients.
  • A multivariable model including prolapse volume provided a superior explanation for left heart chamber enlargement than MR alone.

Conclusions:

  • Prolapse volume is a critical component of the total volume load in Barlow disease.
  • This understanding helps explain the disproportionate LV enlargement observed in Barlow disease relative to MR severity.
Abstract

Related Concept Videos

Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
114
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
202
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
192
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
145
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
140
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
202